Chemed (CHE) Common Equity (2009 - 2026)

Chemed's Common Equity history runs 18 years deep, the most recent figure standing at $848.0 million for Q1 2026.

• In Q1 2026, Common Equity fell 28.24% year-over-year to $848.0 million; the TTM figure through Mar 2026 stood at $848.0 million (down 28.24% YoY), while the FY2025 annual figure was $979.4 million, down 12.47% from the prior year.
• Common Equity was $848.0 million for Q1 2026 at Chemed, down from $979.4 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $1.2 billion in Q3 2024 to a low of $666.7 million in Q1 2022.
• Historically, Common Equity has averaged $991.8 million across 5 years, with a median of $1.0 billion in 2023.
• The sharpest annual moves came in 2023 and 2026: Common Equity surged 41.28% in 2023, then declined 28.24% in 2026.
• A 5-year view of Common Equity shows it stood at $798.7 million in 2022, then jumped by 38.71% to $1.1 billion in 2023, then gained by 1.0% to $1.1 billion in 2024, then declined by 12.47% to $979.4 million in 2025, then fell by 13.42% to $848.0 million in 2026.
• The last three Common Equity figures came in at $848.0 million (Q1 2026), $979.4 million (Q4 2025), and $1.1 billion (Q3 2025), per Business Quant data.